
Iovance Biotherapeutics Inc (IOVA)
NASDAQ
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | -193.77M | -277.85M | -361.82M | -122.28M | -220.71M | -279.68M | -352.98M | -103.69M |
Cash from Investing Activities | -3.38M | -82.4M | -155.24M | -111.51M | -71.29M | -120.09M | -96.41M | 15.87M |
Cash from Financing Activities | 259.2M | 462M | 462.96M | 193.58M | 346.4M | 388.36M | 390.66M | 143.32M |
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | -78.71M | -101.25M | -158.89M | -205.13M | -227.94M | -292.76M | -361.82M | -352.98M |
Cash from Investing Activities | 58.68M | -386.28M | 90.03M | -317.85M | 132k | 256.46M | -155.24M | -96.41M |
Cash from Financing Activities | 58.69M | 424.31M | 6.13M | 576.42M | 239.27M | 190.15M | 462.96M | 390.66M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.